主要有效评估是6分钟步行距离(6mwd)测试，纽约心脏协会功能级别改变以及几种标准呼吸困难等级评分。
Primary efficacy measures were the 6-minute walking distance (6mwd) test, change in New York Heart Association functional class and several standard dyspnoea rating scales.
所有入选者经美国阿帕奇rx- 400心脏彩超仪在治疗前1周内进行心功能测试。
Cardiac function of all subjects was tested with Apache RX-400 color Doppler ultrasonic cardiogram before treatment for 1 week.
所有入选者经美国阿帕奇rx- 400心脏彩超仪在治疗前1周内进行心功能测试。
Cardiac function of all subjects was tested with Apache RX-400 color Doppler ultrasonic cardiogram before treatment for 1 week.
应用推荐